摘要
子宫内膜癌(endometrial carcinoma)是最常见的妇科恶性肿瘤之一。其发生率有逐渐增高的趋势。在2008年,全世界大约有287000例新发子宫内膜癌,在美国,每年大约有43000新发病例,年死亡病例大约为8000例。
出处
《肿瘤预防与治疗》
2012年第4期207-209,共3页
Journal of Cancer Control And Treatment
参考文献19
-
1Jemal A, Siegel R, Xu J,et al. Cancer statistics, 2010 [ J]. CA Cancer J Clin ,2010,60:277-300.
-
2Guntupalli SR, Zighelboim I, Kizer NT. Lymphovascular space in- vasion is an independent risk factor for nodal disease and poor out- comes in endometrioid endometrial cancer [ J ]. Gynecol Oncol, 2012,123(1) :31-35.
-
3Mutch DG. Meeting report : the new FIGO staging system for canc- ers of the vulva, cervix, endometrium and sarcomas [ J]. Gynecol Oncol , 2009,115 : 325- 328.
-
4Boronow RC. Endometrial cancer and lymph node surgery: the spins continue-a case for reason [ J ]. Gynecol Oncol, 2008,111 (1) :3-6.
-
5Morrow CP, Bundy BN, Kurman ill, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study[ J]. Gynecol Oneol , 1991,40:55-65.
-
6Leitao Jr MM. Current and future surgical approaches in the man-agement of endometrial carcinoma [ J ]. Future Oncol , 2008,4 : 389-401.
-
7Abu-Rustum NR, Alektiar K, Iasonos A,, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of u- terine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center [ J ]. Gynecol Oncol , 2006,103 : 714-718.
-
8Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N, et al. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma.'? [ J]. Gynecol Oncol, 2009,113 : 163-169.
-
9Barlin JN, Khoury-Collado F, Kim CH, et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes [ J/OLd. Gynecol Onco1,2012,125 ( 3 ) :531-535.
-
10Mariani A, Dowdy SC, Cliby WA, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging [ J ]. Gynecol Onco1,2008,109 ( 1 ) : 11 - 18.
同被引文献58
-
1Vidal F, Rafii A. Lymph node assessment in endometrial cancer: towards personalized medicine[J]. Obstet Gynecol Int, 2013, 2013:892465. DOI: 10.1155/2013/892465.
-
2De Wilde RL, Rafei A, Herrmann A. Can a lymphadenectomy be avoided in early-stage endometrial adenocarcinoma?[J]. Arch Gynecol Obstet, 2014,290(5):973-978, DOI: 10.1007/ s00404-014-3265-x.
-
3Vargas R, Rauh-Hain JA, Clemmer J, et al. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis[J]. Gynecol Oncol, 2014, 133(2):216-220. DOI: lO.lO16/j. ygyno.2014.02.011.
-
4FIGO Committee on Gynecologic Oncology. FIGO staging for carcinoma of the vulva, cervix, and corpus uteri[J]. Int J Gynaecol Obstet, 2014, 125(2):97-98. DOI: 10.1016/j. ijgo.2014.02.003.
-
5单波尔.基于规范的子宫内膜癌个体优化治疗研究[D].上海:复旦大学,2013.
-
6Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. AGynecologic Oncology Group Study[J]. Cancer, 1987, 60(8 Suppl):2035-2041.
-
7Keys HM, Roberts JA, Brunetto VL, et al. A phase m trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study[J]. Gynecol Oncol, 2004, 92(3):744-751. DOI: 10.1016/j.ygyno.2003.11.048.
-
8Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and 1I carcinoma of the endometrium: a Gynecologic Oncology Group study[J]. Gynecol Oncol, 1991, 40(1):55-65.
-
9SGO Clinical Practice Endometrial Cancer Working Group, Burke WM, Orr J, et al. Endometrial cancer: a review and current management strategies: part I [J]. Gyneeol Oncol, 2014, 134(2):385-392. DOI: 10.1016/j.ygyno.2014.05.018.
-
10Benedetti Paniei P, Basile S, Manesehi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial [J]. J Natl Cancer Inst, 2008, 100(23):1707-1716. DOI: 10.1093/jnei/djn397.
引证文献4
-
1沈杨,王悦,王小元,李丽,Kenneth D.Hatch,Wenxin Zheng,孔北华.子宫内膜癌腹主动脉旁淋巴结切除的相关问题[J].中华妇产科杂志,2016,51(4):310-314. 被引量:7
-
2张庆华,徐文生,蓝喜.Ⅰ型子宫内膜癌患者盆腔淋巴结转移危险因素分析[J].实用妇产科杂志,2017,33(8):603-605. 被引量:15
-
3边立华,孟元光.Ⅰ期子宫内膜癌淋巴结切除临床决策与PET-CT和PET-MRI诊断价值的研究进展[J].中国实用妇科与产科杂志,2018,34(8):945-950. 被引量:11
-
4黄旭鑫(综述),张国楠(审校).宫腔镜在子宫内膜癌保留生育功能治疗中的应用与存在的问题[J].肿瘤预防与治疗,2019,32(2):169-174. 被引量:9
二级引证文献42
-
1刘文波,卢东霞,杨金花,李文华,张凤翔.子宫内膜癌术前分期与分级采取多模态MRI诊断价值分析[J].内蒙古医学杂志,2020(11):1284-1287. 被引量:3
-
2冯珍珍.不同分化程度的子宫内膜癌患者血清PKM2和APN水平表达及临床意义[J].医药论坛杂志,2021,42(15):116-119.
-
3裴燕,王丹.子宫内膜癌患者病理特征与盆腔淋巴结转移的相关性研究[J].世界最新医学信息文摘,2020(11):146-146. 被引量:1
-
4张秀玲.腹主动脉旁淋巴结清扫治疗早期子宫内膜癌的疗效评价[J].实用癌症杂志,2017,32(11):1873-1875. 被引量:8
-
5张靓璠,杜舜兰,朱斌,郭晓丽,庄晓苹.不同主动脉旁淋巴结清扫水平对子宫内膜癌复发的影响[J].中华全科医学,2018,16(5):788-791. 被引量:8
-
6李美艳.子宫内膜癌中VM、VEGF对PLN转移的影响及预后分析[J].河北医科大学学报,2018,39(8):938-942. 被引量:10
-
7王桂荣.子宫内膜癌开腹术中行腹主动脉旁淋巴结切除对术后并发症的影响[J].临床医学,2019,0(5):78-80. 被引量:8
-
8江二喜,曾凡慧.腹主动脉旁淋巴结切除对子宫内膜癌患者预后的影响[J].实用癌症杂志,2018,33(12):2070-2072. 被引量:3
-
9刘丹萍,曾友玲,梅凡.子宫内膜癌淋巴结转移的危险因素及预后分析[J].癌症进展,2019,17(3):348-350. 被引量:19
-
10罗妍,金志军.CO2气腹下腹腔镜淋巴结切除治疗子宫内膜癌的临床效果及对患者QOL评分的影响[J].黑龙江医药科学,2019,42(4):229-231. 被引量:1
-
1Siew.,JR,张应天.胃癌作淋巴结切除术?:评H.D.B...[J].德国医学,1992,9(3):157-157.
-
2高永良.撕剥式盆腔淋巴清扫术[J].中华妇产科杂志,1991,26(5):284-286. 被引量:8
-
3张矛,王康,曹平.直肠癌病理特征与淋巴结转移的关系[J].现代肿瘤医学,2005,13(1):56-57. 被引量:2
-
4恶性肿瘤[J].中国计划生育和妇产科,1999(3):182-186.
-
5师媛,赵淑华,张玲,杨丽娜,朱骞,孙小霞,杨红.卵巢上皮性癌患者术前CA125及人附睾蛋白4水平检测在预测淋巴结转移中的应用[J].中华妇产科杂志,2017,52(3):195-198. 被引量:10
-
6李苏宜,孙新臣,刘琳.乳腺癌治疗五大误区[J].农村百事通,2005(15):59-59.
-
7谢建华.盆腔淋巴结清扫术在Ⅰ期子宫内膜癌治疗中的价值[J].浙江肿瘤,2000,6(2):87-88.
-
8詹文华.推广规范化的胃癌淋巴结清扫术[J].世界华人消化杂志,1999,7(12):1013-1015. 被引量:8
-
9高嘉.腹腔镜手术治疗宫颈癌的临床价值分析[J].中国卫生标准管理,2015,6(9):136-137. 被引量:1
-
10温梅梅.腹腔镜与开腹手术治疗早期卵巢癌的临床疗效比较[J].中国医药导刊,2016,18(10):997-998. 被引量:7